Differential regulation of interleukin-1α and interleukin-1β in K-562 cells

Journal of Interferon and Cytokine Research

Volumn 18, Issue 12, 1998, Pages 1045-1050

  Ichiki, Albert T ^a   Langenberg, Mark ^a,b   Baker, Erich J ^a   Hodge, James W ^c   Bamberger, Elena G ^a   Gerard, David A ^a   Lozzio, Carmen B ^a  

^a UNIVERSITY OF TENNESSEE MEDICAL CENTER   (United States)

^b UNIVERSITY OF TENNESSEE COLLEGE OF MEDICINE   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD61 ANTIGEN; CELL ANTIGEN; GLYCOPROTEIN IIIA; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; UNCLASSIFIED DRUG;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; CYTOKINE RELEASE; ERYTHROLEUKEMIA CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; MEGAKARYOBLAST; MYELOBLAST; PRIORITY JOURNAL;

EID: 0032423320     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.1998.18.1045     Document Type: Article

References (32)

1. DINARELLO, C.A. (1996). Biologic basis for interleukin-1 in disease. Blood 87, 2095-2147.
2. KURZROCK, R., KANTARJIAN, H., WETZLER, M., ESTROV, Z., ESTEY, E., TROUTMAN-WORDEN, K., GUTTERMAN, J.U., and TALPAZ, M. (1993). Ubiquitous expression of cytokines in diverse leukemias of lymphoid and myeloid lineage. Exp. Hematol. 21, 80-85.
3. LOZZIO, C.B., and LOZZIO, B.B. (1975). Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome. Blood 45, 321-334.
4. LOZZIO, B.B., LOZZIO, C.B., ICHIKI, A.T., KALMAZ, G.D., and BAMBERGER, E.G. (1983). K-562: a pluripotent leukemia stem cell line of human origin. In: Haemopoietic Stem Cells, Sv.-Aa. Kellmann, E.P. Cronkite, and C.N. Muller-Berat (eds.) Copenhagen: Munksgaard, Alfred Benzon Symposium 18, pp. 323-337.
5. ICHIKI, A.T., BAMBERGER, E.G., WUST, C.J., and LOZZIO, C.B. (1986). Diversity of cell surface hematopoietic antigens on K-562 sublines identified with monoclonal antibodies. Leuk. Res. 10, 565-574.
6. GERRARD, T.L., BONNARD, G.D., and FAUCI, A.S. (1983). Different requirements for Ia-bearing accessory cells in mitogen versus antigen induction of human B-cell responses. Cell. Immunol. 78, 64-72.
7. WAKASUGI, H., HAREL, A., DOKHELAR, M.C., FRADELIZI, D., and TURSZ, T. (1984). Accessory function and interleukin 1 production by human leukemic cell lines. J. Immunol. 132, 2939-2947.
8. OKUNO, Y., TAKAHASHI, T., SUZUKI, A., FUKUMOTO, M., NAKAMURA, K., and IMURA, H. (1991). Co-production of interleukin-1 and interleukin-6 in tumor cell lines elaborating colony-stimulating factors. Jpn. J. Cancer Res. 82, 890-892.
9. FRUEHAUF, J.P., BONNARD, G.D., and HERBERMAN, R.B. (1982). The effect of lentinan on production of interleukin-1 by human monocytes. Immunopharmacology 5, 65-74.
10. WILLIAMS, J.M., DINARELLO, C.A., ROSENWASSER, L.J., KELLEY, V., REDDISH, M., and STROM, T.B. (1985). Phorbol myristate acetate-protein complex mimics bioactivity of human IL-1. 1. Direct evidence that PMA temporarily enters and is released from cellular compartment during superinduction protocol. Lymphokine Res. 4, 275-297.
11. MIOSSEC, C., DOCOEN, M.-C., DURAND, L., FASSY, F., and DIU-HERCEND, A. (1996). Use of monoclonal antibodies to study interleukin- 1β-converting enzyme expression: only precursor forms are detected in interleukin-1β-secreting cells. Eur. J. Immunol. 26, 1032-1042.
12. SHIBATA, Y., TAKIGUCHI, H., TAMURA, K., YAMANAKA, K., TEZUKA, M., and ABIKO, Y. (1996). Stimulation of interleukin-1 β-converting enzyme activity during growth inhibition by CPT-11 in the human myeloid leukemia cell line K562. Biochem. Mol. Med. 57, 25-30.
13. MARTINS, L.M., MESNER, P.W., KOTTKE, T.J., BASI, G.S., SINHA, S., TUNG, J.S., SVINGEN, P.A., MADDEN, B.J., TAKAHASHI, A., McCORMICK, D.J., EARNSHAW, W.C., and KAUFMANN, S.H. (1997). Comparisons of caspase activation and subcellular localization in HL-60 and K562 cells undergoing etoposide-induced apoptosis. Blood 90, 4283-4296.
14. WAKASUGI, H., HAREL, A., DOKHELAR, M.-C., FRADELIZI, D., and TURSZ, T. (1983). Leukemia cell lines can replace monocytes for mitogen-induced T-lymphocyte responses: this accessory function is dependent upon their differentiation stage. Proc. Natl. Acad. Sci. USA 80, 6028-6031.
15. GRAMATZKI, M., BONNARD, G.D., HERBERMAN, R.B., and STRONG, D.M. (1985). Characterization of cell lines enhancing IL-2 production by human phytohemagglutinin-stimulated lymphocytes. Cell. Immunol. 90, 142-153.
16. HOUSSIAU, F.A., COULEE, P.G., and VAN SNICK, J. (1989). Distinct roles of IL-1 and IL-6 in human T cell activation. J. Immunol. 143, 2520-2524.
17. CAWLEY, J.C., and HAYHOE, F.G.J. (1973). Ultrastructure of Haemic Cells. Philadelphia: W.B. Saunders, pp. 117-118.
18. FENTON, M.J., VERMEULEN, M.W., CLARK, B.D., WEBB, A.C., and AURON, P.E. (1988). Human pro-IL-1β gene expression in monocytic cells is regulated by two distinct pathways. J. Immunol. 140, 2267-2273.
19. BRANTSCHEN, S., GAUCHAT, J.-F., DE WECK, A.L., and STADLER, B.M. (1989). Differential expression of cytokine mRNAs in human cell lines. Lymphokine Res. 8, 163-172.
20. MARTIN, M., LOVETT, D., and RESCH, K. (1986). Interleukin 1 induces specific phosphorylation of a 41 kDa plasma membrane protein from the human tumor cell line K 562. Immunobiology 171, 165-169.
21. WEITZMANN, M.N., and SAVAGE, N. (1993). Failure of interleukin-1 to induce intracellular calcium fluxes in K562 cells. Life Sci. 53, PL95-97.
22. AKIN, C., and SONNENFELD, G. (1996). Stimulation of granulocyte-macrophage colony-stimulating factor (GM-CSF) production and its role as an autocrine inducer of CD14 upregulation in human myeloid leukemia cells. J. Interferon Cytokine Res. 16, 479-486.
23. NAVARRO, S., MITJAVILA, M.T., KATZ, A., DOLY, J., and VAINCHENKER, W. (1991). Expression of interleukin 6 and its specific receptor by untreated and PMA-stimulated human erythroid and megakaryocytic cell lines. Exp. Hematol. 19, 11-17.
24. TALLEY, C.J., TURNER, E.A., HATCHER, F.M., AGUINAGA, P.M., and CHAKRABARTI, P. (1997). Tiazofurin-induced autosecretion of IL-6 and hemoglobin production in K562 human leukemia cells. Am. J. Hematol. 54, 301-305.
25. HASSAN, H.T., and DREXLER, H.G. (1995). Interleukins and colony stimulating factors in human myeloid leukemia cell lines. Leuk. Lymphoma 20, 1-15.
26. AVALOS, B.R., KAUFMAN, S.E., TOMONAGA, M., WILLIAMS, R.E., GOLDE, D.W., and GASSON, J.C. (1988). K562 cells produce and respond to human erythroid-potentiating activity. Blood 71, 1720-1725.
27. ALITALO, R., MAKELA, T.P., KOSKINEN, P., ANDERSSON, L.C., and ALITALO, K. (1988). Enhanced expression of transforming growth factor β during megakaryoblastic differentiation of K562 leukemia cells. Blood 71, 899-906.
28. OLOFSSON, T., and CLINE, M.J. (1978). Inhibitor of hematopoietic cell proliferation derived from a human leukemic cell line. Blood 52, 143-152.
29. KORZELIUS, J.M., BEALMEAR, P.M., and HOLTERMANN, O.A. (1983). Suppressor substance produced by the K562 cell line in vitro. J. Surg. Oncol. 23, 16-20.
30. HAYAMIZU, K., YAHATA, H., FUKUDA, Y., and DOHI, K. (1993). Induction of natural suppressor-like cells from human adult peripheral blood lymphocytes by a K562-derived factor. Transplantation 55, 1403-1408.
31. TETTEROO, P.A.T., MASSARO, F., MULDER, A., SCHREUDER-VAN GELDER, R., and VON DEM BORNE, A.E.G.K. (1984). Megakaryoblastic differentiation of proerythroblastic K562 cell-line cells. Leuk. Res. 8, 197-206.
32. SUTHERLAND, J.A., TURNER, A.R., MANNONI, P., McGANN, L.E., and TURC, J.-M. (1986). Differentiation of K562 leukemia cells along erythroid, macrophage, and megakaryocyte lineages. J. Biol. Res. Mod. 5, 250-262.